Weight Loss News and Research RSS Feed - Weight Loss News and Research

IBD patients are at higher risk of melanoma, report researchers

IBD patients are at higher risk of melanoma, report researchers

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla. [More]

Study suggests that fluid, sodium restrictions have no effect on weight loss in ADHF patients

A clinical trial of 75 patients hospitalized with acute decompensated heart failure suggests that aggressive fluid and sodium restriction has no effect on weight loss or clinical stability at three days but was associated with an increase in perceived thirst, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication. [More]
Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22. [More]
Newer class of diabetes medications may also improve cardiovascular health, researchers report

Newer class of diabetes medications may also improve cardiovascular health, researchers report

A newer class of medications used to control blood sugar levels in type 2 diabetics may also improve cardiovascular health, researchers from The Ohio State University Wexner Medical Center reported in a new meta-analysis presented yesterday at the American Society of Hypertension's Annual Scientific Meeting and Exposition. [More]
Galapagos, AbbVie announce extension of GLPG0634 clinical development collaboration

Galapagos, AbbVie announce extension of GLPG0634 clinical development collaboration

Galapagos NV and AbbVie announced today an extension of their GLPG0634 clinical development collaboration to include Crohn's disease. Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3. [More]
Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. [More]
Loyola University Health System creates new weapon to fight against obesity

Loyola University Health System creates new weapon to fight against obesity

In the past 30 years the number of children living in the U.S. who are obese has more than doubled and the number of adolescents has tripled. In response, Loyola University Health System has created a Pediatric Weight Management Program designed to help families and communities in the fight against this epidemic. [More]

UFC releases first ever in-home fitness and nutrition program

The secrets of the Ultimate Fighting Championship's elite athletes are finally revealed in UFC FIT - the UFC's first ever in-home fitness and nutrition program. [More]
Statistics reveal that about 79 million adult Americans walk around with prediabetes

Statistics reveal that about 79 million adult Americans walk around with prediabetes

Diabetes is one of the most misunderstood medical conditions. "It's not just about sugar. It's about your heart," says Nancy Ryan, RD, BC-ADM, a registered dietitian, board-certified in advanced diabetes management at Greenwich Hospital in Greenwich, Connecticut. [More]
Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA). [More]

Research shows fish oils could minimize effects of junk food on brain

Data from more than 180 research papers suggests fish oils could minimise the effects that junk food can have on the brain, a review by researchers at the University of Liverpool has shown. [More]

Increasing body fat after middle age makes arteries stiffer, new study reveals

Having too much body fat makes arteries become stiff after middle age, a new study has revealed. [More]
Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC. [More]
Early limited formula can provide important benefits to some newborns

Early limited formula can provide important benefits to some newborns

Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding. [More]
People with job strain, unhealthy lifestyle are at higher risk of coronary artery disease, study finds

People with job strain, unhealthy lifestyle are at higher risk of coronary artery disease, study finds

People with job stress and an unhealthy lifestyle are at higher risk of coronary artery disease than people who have job stress but lead healthy lifestyles, found a study published in CMAJ. [More]

University of Liverpool researchers develop smart phone app that promotes weight loss

Researchers at the University of Liverpool have developed a smart phone app that helps users lose weight by carefully recording their food consumption. [More]

Nutritional supplement may improve survival rates of babies born with heart defects

A common nutritional supplement may be part of the magic in improving the survival rates of babies born with heart defects, researchers report. Carnitine, a compound that helps transport fat inside the cell powerhouse where it can be used for energy production, is currently used for purposes ranging from weight loss to chest pain. [More]
FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced today that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older. [More]
Frequent use of workplace wellness center improves overall quality-of-life

Frequent use of workplace wellness center improves overall quality-of-life

People who used a workplace wellness center on frequent basis reported an improvement in their overall quality-of-life, while those that used the center less often reported no improvements in their physical quality-of-life and a decline in their mental quality-of-life, finds a new study in the American Journal of Health Promotion. [More]

ITM researchers develop, test a combination of tools to diagnose SN-TB

Researchers at the Institute of Tropical Medicine have successfully developed and tested a combination of simple clinical, radiological and laboratory tools to diagnose smear-negative tuberculosis. [More]